In this line of research, pharmacological treatments used to treat other diseases, such as hypertension (i.e., calcium channel blockers) [58,59] or hypercholesterolemia (i.e., statins) [60,61], were postulated as therapeutic agents against AD, given their alleged anti-inflammatory and insulin sensitizing properties. This evidence concerns the gene INS and Alzheimer disease.